# DABIGATRAN

NDC: 50090-7531
Generic name: DABIGATRAN ETEXILATE
Labeler / Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20240522

FDA application: ANDA213879

## Active ingredients

- DABIGATRAN ETEXILATE MESYLATE: 75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-7531"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-7531
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bee57f1b-ee5f-4f81-ae6f-ea65ddf9a174